News

Select Category
News & Insights
September 7, 2022

Aqemia is one of "the 21 most promising healthtech startups of 2022, according to top VCs" in Business Insider

News & Insights
September 7, 2022

Aqemia is one of "the 21 most promising healthtech startups of 2022, according to top VCs" in Business Insider

News & Insights
September 5, 2022

Aqemia has been selected to participate to the second edition of the Saclay-Boston Biotech Masterclass organized by Servier and BioLabs France

We will then travel to Boston from Nov 7 to Nov 11 for an immersion week with 5 other innovative biotech companies, in the heart of the most innovative biotech ecosystem in the world. On the agenda: workshops, conferences, Lunch & Learn, visits, B2B meetings and networking events to meet the Life Sciences actors in Cambridge.
News & Insights
September 5, 2022

Aqemia has been selected to participate to the second edition of the Saclay-Boston Biotech Masterclass organized by Servier and BioLabs France

We will then travel to Boston from Nov 7 to Nov 11 for an immersion week with 5 other innovative biotech companies, in the heart of the most innovative biotech ecosystem in the world. On the agenda: workshops, conferences, Lunch & Learn, visits, B2B meetings and networking events to meet the Life Sciences actors in Cambridge.
News & Insights
August 22, 2022

In a special report based on Nature Portfolio, Fierce Biotech ranked the top 10 global R&D institutes of 2021.

Fierce Biotech ranked CNRS as one of the world's top research institutions. With more than 1700 startups that have emerged from their labs, "None sounded more cutting-edge than Aqemia, a drug discovery company that uses AI and unique quantum-inspired algorithms to speed up the discovery of innovative molecules."
News & Insights
August 22, 2022

In a special report based on Nature Portfolio, Fierce Biotech ranked the top 10 global R&D institutes of 2021.

Fierce Biotech ranked CNRS as one of the world's top research institutions. With more than 1700 startups that have emerged from their labs, "None sounded more cutting-edge than Aqemia, a drug discovery company that uses AI and unique quantum-inspired algorithms to speed up the discovery of innovative molecules."
News & Insights
June 15, 2022

Aqemia Announces an Extension of Its First Collaboration With Sanofi About AI and Quantum Physics-driven Drug Discovery in Oncology

This new agreement is a follow-up to a Research Collaboration initiated at the end 2020 by Sanofi to bring the unique technologies of Aqemia to the design and discovery of novel molecules in several projects in oncology, a priority therapeutic area for Sanofi.
News & Insights
June 15, 2022

Aqemia Announces an Extension of Its First Collaboration With Sanofi About AI and Quantum Physics-driven Drug Discovery in Oncology

This new agreement is a follow-up to a Research Collaboration initiated at the end 2020 by Sanofi to bring the unique technologies of Aqemia to the design and discovery of novel molecules in several projects in oncology, a priority therapeutic area for Sanofi.
News & Insights
June 3, 2022

Aqemia is pleased to welcome you to the heart of its innovation!

Aqemia will host its first event the 23th of June.
News & Insights
June 3, 2022

Aqemia is pleased to welcome you to the heart of its innovation!

Aqemia will host its first event the 23th of June.